NeuroMetrix reports data from Quell trial for treatment of fibromyalgia; shares up 7%

Register to chat with like-minded investors on our interactive forums.

Get Started

NeuroMetrix reports data from Quell trial for treatment of fibromyalgia; shares up 7%

To read the full story on Seeking Alpha, click here.

NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more NeuroMetrix Charts.

NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more NeuroMetrix Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

NeuroMetrix Inc News

More NeuroMetrix Inc News Articles

Sincerity Applied Materi... (PK)

Brookmount Explorations (PK)

TransCode Therapeutics

Net Savings Link (PK)

Premier Biomedical (PK)

Clean Vision (QB)

Revance Therapeutics

NFT MarketPlace (PK)

Delayed Upgrade Clock